IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novelion Therapeutics Inc

Q1 2017 vs Q2 2017

Comparing institutional holders between quarters

Quarters

Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Bartlett & Co. LLC
UNCHANGED
Shares400 from 400
Change0 (0%)
Value$4 ($0)
Filed 2017-07-18
Status
Bartlett & Co. LLC
UNCHANGED40040000%$4$4$02017-07-18
Showing 1 of 1 institutions